Geron Ownership | Who Owns Geron?
Geron Ownership Summary
Geron is owned by 76.95% institutional investors, 0.09% insiders, and 22.96% retail investors. Blackrock is the largest institutional shareholder, holding 7.71% of GERN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.94% of its assets in Geron shares.
GERN Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Geron | 76.95% | 0.09% | 22.96% |
Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock | 46.55M | 7.71% | $197.38M |
Ra capital management | 46.20M | 7.66% | $195.90M |
Vanguard group | 31.93M | 5.29% | $135.40M |
Vivo capital | 27.23M | 4.51% | $115.44M |
Darwin global management | 23.92M | 3.96% | $106.18M |
State street | 22.55M | 3.74% | $95.61M |
Jefferies financial group | 20.03M | 3.32% | $84.93M |
Adage capital partners gp | 19.73M | 3.27% | $83.63M |
Woodline partners lp | 16.95M | 2.81% | $71.87M |
Farallon capital management | 16.84M | 2.79% | $71.39M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Darwin global management | 23.92M | 12.35% | $106.18M |
Vivo capital | 27.23M | 10.66% | $115.44M |
Ally bridge group (ny) | 2.74M | 6.91% | $11.60M |
Nan fung group | 1.37M | 6.21% | $5.82M |
Lion point capital, lp | 630.00K | 4.87% | $2.67M |
Bridger management | 1.34M | 2.92% | $5.67M |
Ra capital management | 46.20M | 2.59% | $195.90M |
Deep track capital, lp | 13.00M | 1.65% | $55.12M |
Boxer capital | 6.00M | 1.34% | $25.44M |
Silverarc capital management | 999.27K | 1.00% | $4.24M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Darwin global management | 23.92M | 12.35% | 23.92M |
Jefferies financial group | 20.03M | 0.90% | 19.85M |
Woodline partners lp | 16.95M | 0.69% | 15.74M |
Adage capital partners gp | 19.73M | 0.15% | 12.53M |
Farallon capital management | 16.84M | 0.34% | 9.34M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Deep track capital, lp | 13.00M | 1.65% | -17.51M |
Tcg crossover management | - | - | -17.39M |
Bioimpact capital | - | - | -10.48M |
Nea management company | 2.78M | 0.89% | -10.00M |
State street | 22.55M | 0.00% | -9.06M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Darwin global management | 23.92M | 12.35% | 23.92M | $106.18M |
Eventide asset management | 6.36M | 0.46% | 6.36M | $26.95M |
Eam investors | 744.27K | 0.51% | 744.27K | $3.16M |
First trust advisors lp | 692.86K | 0.00% | 692.86K | $2.94M |
Artisan partners limited partnership | 383.73K | 0.00% | 383.73K | $1.63M |
Sold Out
Holder | Change |
---|---|
Smartleaf asset management | -64.00 |
Nelson, van denburg & campbell wealth management group | -96.00 |
Principal securities | -150.00 |
Innealta capital | -264.00 |
Newbridge financial services group | -400.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 244 | 2.52% | 464,410,765 | 7.02% | 76 | 1.49% | 137 | 16.10% | 51 | -16.39% |
Mar 31, 2024 | 238 | 14.42% | 433,927,613 | 10.37% | 71 | 1.65% | 118 | 24.21% | 61 | 24.49% |
Dec 31, 2023 | 208 | 0.48% | 393,141,349 | 6.01% | 66 | 1.61% | 95 | -14.41% | 49 | 44.12% |
Sep 30, 2023 | 207 | 0.49% | 370,859,252 | 7.74% | 63 | 1.62% | 111 | 5.71% | 34 | -22.73% |
Jun 30, 2023 | 206 | 5.64% | 344,209,800 | 5.80% | 62 | 1.76% | 105 | -8.70% | 44 | 22.22% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 17.73M | 2.94% | -101.33K |
SPDR® S&P Biotech ETF | 15.70M | 2.61% | 173.78K |
iShares Russell 2000 ETF | 14.96M | 2.48% | -33.64K |
Vanguard Institutional Extnd Mkt Idx Tr | 7.81M | 1.30% | -236.87K |
Eventide Healthcare & Life Sciences I | 6.36M | 1.05% | 6.36M |
Fidelity Small Cap Index | 5.90M | 0.98% | -144.97K |
Fidelity Select Biotechnology | 5.81M | 0.96% | -456.70K |
Fidelity Growth Compy Commingled Pl S | 4.31M | 0.72% | 25.11K |
Fidelity Growth Compy Commingled Pl O | 4.29M | 0.71% | - |
iShares Biotechnology ETF | 3.88M | 0.64% | -40.46K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jul 08, 2024 | GRETHLEIN ANDREW J | EVP, Chief Operating Officer | Sell | $3.07M |
Jun 10, 2024 | Feller Faye | EVP, Chief Medical Officer | Sell | $1.33M |
Jun 10, 2024 | Kapur Anil | EVP, Corp Strategy & CCO | Sell | $1.96M |
Jun 04, 2024 | SCARLETT JOHN A | Chairman, President and CEO | Sell | $2.40M |
May 15, 2024 | LAWLIS V BRYAN | - | Sell | $131.25K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q3 | - | 1 |
2024 Q2 | - | 4 |
2024 Q1 | - | - |
2023 Q4 | - | - |
GERN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools